{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T17:56:05Z","timestamp":1770573365121,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s12149-008-0156-x","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T18:07:26Z","timestamp":1219946846000},"page":"557-564","source":"Crossref","is-referenced-by-count":37,"title":["Usefulness of rCBF analysis in diagnosing Parkinson\u2019s disease: supplemental role with MIBG myocardial scintigraphy"],"prefix":"10.1007","volume":"22","author":[{"given":"Shigeki","family":"Nagamachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemi","family":"Futami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syuichi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Arita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"156_CR1","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","volume":"32","author":"D.B. Calne","year":"1992","unstructured":"Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson\u2019s disease. Ann Neurol 1992;32:S125\u2013S127.","journal-title":"Ann Neurol"},{"key":"156_CR2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000022147","volume":"46","author":"H. Nagayama","year":"2000","unstructured":"Nagayama H, Hamamoto M, Nito C, Takagi S, Miyazaki T, Katayama Y. Initial symptoms of Parkinson\u2019s disease with elderly onset. Gerontology 2000;46:129\u2013132.","journal-title":"Gerontology"},{"key":"156_CR3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(72)90571-5","volume":"1","author":"M. Gross","year":"1972","unstructured":"Gross M, Bannister R, Godwin-Austen R. Orthostatic hypotension in Parkinson\u2019s disease. Lancet 1972;1:174\u2013176.","journal-title":"Lancet"},{"key":"156_CR4","first-page":"22","volume":"22","author":"D.M. Wieland","year":"1981","unstructured":"Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22\u201331.","journal-title":"J Nucl Med"},{"key":"156_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","volume":"19","author":"M. Yoshita","year":"1998","unstructured":"Yoshita M, Hayashi M, Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson\u2019s disease. Nucl Med Commun 1998;19:137\u2013142.","journal-title":"Nucl Med Commun"},{"key":"156_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S. Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1999;67:189\u2013194.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"156_CR7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S. Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I] MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology 1999;53:1020\u20131025.","journal-title":"Neurology"},{"key":"156_CR8","first-page":"71","volume":"41","author":"H. Takatsu","year":"2000","unstructured":"Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000;41:71\u201377.","journal-title":"J Nucl Med"},{"key":"156_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02984560","volume":"18","author":"J. Taki","year":"2004","unstructured":"Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004;18:453\u2013461.","journal-title":"Ann Nucl Med"},{"key":"156_CR10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF00256942","volume":"15","author":"D. Fagret","year":"1989","unstructured":"Fagret D, Wolf JE, Comet M. Myocardial uptake of meta-[123I]-iodobenzylguanidine [(123I)-MIBG] in patients with myocardial infarct. Eur J Nucl Med 1989;15:624\u2013628.","journal-title":"Eur J Nucl Med"},{"key":"156_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF03164921","volume":"12","author":"S. Nagamachi","year":"1998","unstructured":"Nagamachi S, Jinnouchi S, Kurose T, Ohnishi T, Flores LG II, Nakahara H, et al. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function. Ann Nucl Med 1998;12:323\u2013331.","journal-title":"Ann Nucl Med"},{"key":"156_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00005344-199201000-00002","volume":"19","author":"P. Merlet","year":"1992","unstructured":"Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, et al. Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992;19:10\u201316.","journal-title":"J Cardiovasc Pharmacol"},{"key":"156_CR13","first-page":"208","volume":"33","author":"S. Wakasugi","year":"1992","unstructured":"Wakasugi S, Wada A, Hasegawa Y, Nakano S, Shibata N. Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. J Nucl Med 1992;33:208\u2013214.","journal-title":"J Nucl Med"},{"key":"156_CR14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.20369","volume":"5","author":"J. Spiegel","year":"2005","unstructured":"Spiegel J, Mollers MO. FP-CIT and MIBG scintigraphy in early. Mov Disord 2005;5:552\u2013561.","journal-title":"Mov Disord"},{"key":"156_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"T.S. Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503\u2013510.","journal-title":"Mov Disord"},{"key":"156_CR16","first-page":"1583","volume":"40","author":"Y. Imon","year":"1999","unstructured":"Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson\u2019s disease. J Nucl Med 1999;40:1583\u20131589.","journal-title":"J Nucl Med"},{"key":"156_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/01.mnm.0000243370.18883.62","volume":"27","author":"M. Derejko","year":"2006","unstructured":"Derejko M, Slawek J, Wieczorek D, Brockhuis B, Dubaniewicz M, Lass P. Regional cerebral blood flow in Parkinson\u2019s disease as an indicator of cognitive impairment. Nucl Med Commun 2006;27:945\u2013951.","journal-title":"Nucl Med Commun"},{"key":"156_CR18","first-page":"15","volume":"81","author":"Y. Mito","year":"2006","unstructured":"Mito Y, Yoshida K, Yabe I, Makino K, Tashiro K, Kikuchi S, et al. Brain SPECT analysis by 3D-SSP and clinical features of Parkinson\u2019s disease. Hokkaido Igaku Zasshi 2006;81:15\u201323.","journal-title":"Hokkaido Igaku Zasshi"},{"key":"156_CR19","first-page":"29","volume":"58","author":"T. Sakai","year":"2006","unstructured":"Sakai T, Kuzuhara S. Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson\u2019s disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT (in Japanese). No To Shinkei 2006;58:29\u201337.","journal-title":"No To Shinkei"},{"key":"156_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1212\/WNL.52.3.541","volume":"52","author":"N.I. Bohnen","year":"1999","unstructured":"Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Motor correlates of occipital glucose hypometabolism in Parkinson\u2019s disease without dementia. Neurology 1999;52:541\u2013546.","journal-title":"Neurology"},{"key":"156_CR21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1212\/01.wnl.0000187116.13370.e0","volume":"65","author":"N. Oishi","year":"2005","unstructured":"Oishi N, Udaka F, Kameyama M, Sawamoto N, Hashikawa K, Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708\u20131715.","journal-title":"Neurology"},{"key":"156_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(99)00011-8","volume":"163","author":"Y. Arahata","year":"1999","unstructured":"Arahata Y, Hirayama M, Ieda T, Koike Y, Kato T, Tadokoro M, et al. Parieto-occiptal glucose hypometabolism in Parkinson\u2019s disease with autonomic failure. J Neurol Sci 1999;163:119\u2013126.","journal-title":"J Neurol Sci"},{"key":"156_CR23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.parkreldis.2005.01.001","volume":"11","author":"H. Matsui","year":"2005","unstructured":"Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. Brain perfusion differences between Parkinson\u2019s disease and multiple system atrophy with predominant parkinsonian features. Parkinsonism Relat Disord 2005;11:227\u2013232.","journal-title":"Parkinsonism Relat Disord"},{"key":"156_CR24","first-page":"933","volume":"45","author":"K. Laere Van","year":"2004","unstructured":"Van Laere K, Santens P, Bosman T, Reuck JD, Mortelmans L, Dierckx R. Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson\u2019s disease and multiple system atrophy with predominant parkinsonian features: correlations with clinical parameters. J Nucl Med 2004;45:933\u2013942.","journal-title":"J Nucl Med"},{"key":"156_CR25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp.74.4.419","volume":"74","author":"Y. Abe","year":"2003","unstructured":"Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, et al. Occipital hypoperfusion in Parkinson\u2019s disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419\u2013422.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"156_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"M.M. Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427\u2013442.","journal-title":"Neurology"},{"key":"156_CR27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mds.21220","volume":"22","author":"L.N. Williams","year":"2007","unstructured":"Williams LN, Seignourel P, Crucian GP, Okun MS, Rodriguez RL, Skidmore FM, et al. Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson\u2019s disease. Mov Disord 2007;22:141\u2013145.","journal-title":"Mov Disord"},{"key":"156_CR28","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/mds.21105","volume":"21","author":"H.L. Katzen","year":"2006","unstructured":"Katzen HL, Levin BE, Weiner W. Side and type of motor symptom influence cognition in Parkinson\u2019s disease. Mov Disord 2006;21:1947\u20131953.","journal-title":"Mov Disord"},{"key":"156_CR29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","volume":"77","author":"D.J. Burn","year":"2006","unstructured":"Burn DJ, Rowan EN, Allan LM, Molloy S, O\u2019Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Levy bodies. J Neurol Neurosurg Psychiatry 2006;77:585\u2013589.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"156_CR30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF01254564","volume":"22","author":"H. Matsuda","year":"1995","unstructured":"Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1995;22:633\u2013637.","journal-title":"Eur J Nucl Med"},{"key":"156_CR31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00259-001-0715-z","volume":"29","author":"R. Takeuchi","year":"2002","unstructured":"Takeuchi R, Yonekura Y, Matsuda H, Konishi J. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging 2002;29:331\u2013341.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"156_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autneu.2005.03.003","volume":"119","author":"H. Matsui","year":"2005","unstructured":"Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson\u2019s disease and multiple system atrophy. Auton Neurosci 2005;119:56\u201360.","journal-title":"Auton Neurosci"},{"key":"156_CR33","first-page":"60","volume":"155","author":"M. Yoshita","year":"1998","unstructured":"Yoshita M. Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 metaiodobenzylguanidine myocardial scintigraphy. J Neurosci 1998;155:60\u201367.","journal-title":"J Neurosci"},{"key":"156_CR34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S. Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, L\u00fccking CH. Cardiac uptake of [123I] MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology 1999;53:1020\u20131025.","journal-title":"Neurology"},{"key":"156_CR35","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1212\/WNL.35.10.1399","volume":"35","author":"L.I. Wolfson","year":"1985","unstructured":"Wolfson LI, Leenders KL, Brown LL, Jones T. Alteration of cerebral blood flow and oxygen metabolism in Parkinson\u2019s disease. Neurology 1985;35:1399\u20131405.","journal-title":"Neurology"},{"key":"156_CR36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1471301204039324","volume":"3","author":"Y. Arahata","year":"2004","unstructured":"Arahata Y, Kato T, Ito K, et al. PET and SPECT studies in Parkinson\u2019s disease with dementia. Cogn Dement 2004;3:45\u201349.","journal-title":"Cogn Dement"},{"key":"156_CR37","first-page":"754","volume":"66","author":"K. Ito","year":"1999","unstructured":"Ito K, Morrish PK, Rakshi JS, Uema T, Ashburner J, Bailey DL, et al. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson\u2019s disease. J Neurosurg 1999;66:754\u2013758.","journal-title":"J Neurosurg"},{"key":"156_CR38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archneur.1997.00550140025008","volume":"54","author":"V.A. Holthoff-Detto","year":"1997","unstructured":"Holthoff-Detto VA, Kessler J, Herholz K, Bonner H, Pietrzyk U, Wurker M, et al. Functional effects of striatal dysfunction in Parkinson disease. Arch Neurol 1997;54:145\u2013150.","journal-title":"Arch Neurol"},{"key":"156_CR39","first-page":"1456","volume":"41","author":"F. Tanaka","year":"2000","unstructured":"Tanaka F, Vines D, Tsuchida T, Freedman M, Ichise M. Normal patterns on 99mTc-ECD brain SPECT scans in adults. J Nucl Med 2000;41:1456\u20131464.","journal-title":"J Nucl Med"},{"key":"156_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02985625","volume":"20","author":"H. Ito","year":"2006","unstructured":"Ito H, Inoue K, Goto R, Kinomura S, Taki Y, Okada K, et al. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry. Ann Nucl Med 2006;20:131\u2013138.","journal-title":"Ann Nucl Med"},{"key":"156_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00401-002-0651-4","volume":"105","author":"N. Hishikawa","year":"2003","unstructured":"Hishikawa N, Hashizume Y, Yoshida M, Sobue G. Clinical and neuropathological correlates of Lewy body disease. ACTA Neuropathol 2003;105:341\u2013350.","journal-title":"ACTA Neuropathol"},{"key":"156_CR42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","volume":"47","author":"R.L. Albin","year":"1996","unstructured":"Albin RL, Minoshima S, D\u2019Amato CJ, Frey KA, Kuhl DE, Sima AAF. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996;47:462\u2013466.","journal-title":"Neurology"},{"key":"156_CR43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","volume":"117","author":"G.K. Wenning","year":"1994","unstructured":"Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835\u2013845.","journal-title":"Brain"},{"key":"156_CR44","first-page":"117","volume-title":"Brain morphology and function: recent development in neuroimaging","author":"H. Fukuda","year":"2005","unstructured":"Fukuda H. Brain morphology and function: recent development in neuroimaging. 1st ed. Tokyo: Shinko Igaku; 2005. p. 117\u2013127.","edition":"1"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-008-0156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-008-0156-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-008-0156-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:34:41Z","timestamp":1588898081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-008-0156-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["156"],"URL":"https:\/\/doi.org\/10.1007\/s12149-008-0156-x","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}